 rational therapeutic strategy arachnoiditis possible role d-penicillamine Twenty-six patients men women age years surgical and/or radiculographic evidence chronic adhesive spinal arachnoiditis CASA double-blind crossover trial d-penicillamine mg/day versus placebo Assessments subjective objective criteria intervals significant effect d-penicillamine placebo Thirteen patients trial clear preference patient placebo patients strong preference d-penicillamine objective data improvement long-term therapy years small subgroup patients CASA d-penicillamine therapy